
-
'Alarming deterioration' of US press freedom under Trump, says RSF
-
Hard right makes early gains as local polls test UK's main parties
-
China says open to US trade talks offer but wants tariffs scrapped
-
Climate change takes spice from Indonesia clove farms
-
Bruised Real Madrid must stay in title fight against Celta
-
Top-five race heats up as Saints try to avoid unwanted history
-
Asian stocks gain after China teases US tariff talks
-
South Korea former PM launches presidential bid
-
Mueller eyes one final title as Bayern exit draws near
-
Canelo aims to land knockout blow against Scull in Saudi debut
-
Lions hopefuls get one last chance to shine with Champions Cup semis
-
Trump vs Toyota? Why US cars are a rare sight in Japan
-
Ryu, Ariya shake off major letdowns to start strong in Utah
-
Sean 'Diddy' Combs: the rap mogul facing life in prison
-
Sean 'Diddy' Combs sex crimes trial to begin Monday
-
Backyard barnyard: rising egg prices prompt hen hires in US
-
Trinidad leader sworn in, vows fresh start for violence-weary state
-
US veteran convicted of quadruple murder executed in Florida
-
UK comedian Russell Brand due in court on rape charges
-
Tokyo's tariff envoy says US talks 'constructive'
-
Ledecky out-duels McIntosh in sizzing 400m free
-
Scheffler grabs PGA lead with sizzling 61 at CJ Cup Byron Nelson
-
'Divine dreams' and 38 virgins at Trump prayer event
-
Apple expects $900 mn tariff hit, US iPhone supply shifts to India
-
Lakers prepare for offseason rebuild after playoff exit
-
'Natural' for stars like Maguire to deliver now: Man Utd's Amorim
-
EU preparing new sanctions on Russia, French minister tells AFP
-
Apple expects $900 mn tariff hit as shifts US iPhone supply to India
-
US to end shipping loophole for Chinese goods Friday
-
Forest's Champions League dreams hit by Brentford defeat
-
Norris and Piastri taking championship battle in their stride
-
Chelsea close in on UEFA Conference League final with win at Djurgarden
-
Spurs take control in Europa semi against Bodo/Glimt
-
Man Utd seize control of Europa League semi against 10-man Bilbao
-
With minerals deal, Ukraine finds way to secure Trump support
-
Amazon revenue climbs 9%, but outlook sends shares lower
-
Trump axes NSA Waltz after chat group scandal
-
Forest Champions League dreams hit after Brentford defeat
-
'Resilient' Warriors aim to close out Rockets in bruising NBA playoff series
-
US expects Iran talks but Trump presses sanctions
-
Baffert returns to Kentucky Derby, Journalism clear favorite
-
Top Trump security official replaced after chat group scandal
-
Masked protesters attack Socialists at France May Day rally
-
Mumbai eliminate Rajasthan from IPL playoff race with bruising win
-
McDonald's profits hit by weakness in US market
-
Rio goes Gaga for US singer ahead of free concert
-
New research reveals where N. American bird populations are crashing
-
Verstappen late to Miami GP as awaits birth of child
-
Zelensky says minerals deal with US 'truly equal'
-
Weinstein lawyer says accuser sought payday from complaint
CMSC | 0.09% | 22.03 | $ | |
RBGPF | 100% | 67.21 | $ | |
RYCEF | -0.99% | 10.12 | $ | |
VOD | -0.31% | 9.73 | $ | |
NGG | -1.88% | 71.65 | $ | |
SCS | -0.51% | 9.87 | $ | |
BTI | -0.58% | 43.3 | $ | |
GSK | -2.84% | 38.75 | $ | |
AZN | -1.82% | 70.51 | $ | |
RIO | -1.45% | 58.55 | $ | |
CMSD | -0.18% | 22.26 | $ | |
RELX | -1.02% | 54.08 | $ | |
JRI | 0.77% | 13.01 | $ | |
BCC | -0.61% | 92.71 | $ | |
BP | 1.51% | 27.88 | $ | |
BCE | -3.78% | 21.44 | $ |

Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
J.Williams--AMWN